TheJobsMapAbout MODAG
MODAG aims to provide a novel approach for treating neurodegenerative diseases by combining targeted small molecule therapeutics with the right diagnostic tools. Their first objective is to demonstrate clinical proof-of-concept with their lead compound anle138b in Multiple System Atrophy (MSA) seeking to halt the progression and provide a firstdisease-modifying therapeutic.This success will allow us to apply their technology to similar diseases such as Parkinson’s and other synucleinopathies with the goal of dissolving disease-related intra-cellular oligomers, thereby reducing their toxic properties.MODAG is comprised of experts in the clinical research and neurodegenerative disease space and supported by grants from leading patient organizations including the Michael J Fox Foundation, Cure Parkinson's Trust and Parkinson’s UK.
Founded in 2013 by Armin Giese and Torsten Matthias.
- Founded
- 2013
- Employees
- 11 to 50
- Total funding
- $12M
- Headquarters
- Wendelsheim
Leadership
The top of MODAG's org chart, with how many people report into each leader.
Prof. Armin Giese
Chief Scientific Officer
4 reports
Daniel Weckbecker
Research And Development Scientist
2 reports
Mareike Rode
Management Assistant
Jobs at MODAG
No open positions right now. Explore more companies on TheJobsMap.